When BP Is 180/80: Which Drug Best Targets Systolic Hypertension?
When BP Is 180/80: Which Drug Best Targets Systolic Hypertension?
Short Answer
Thiazide-like diuretics provide the greatest and most consistent reduction in systolic blood pressure (SBP) and remain the most widely used first-line agents, particularly in isolated systolic hypertension.
Why Thiazide-Like Diuretics Lead
• Chlorthalidone and indapamide achieve the strongest SBP reduction
• Best evidence in isolated systolic hypertension
• Proven reduction in stroke and cardiovascular events
• Recommended as first-line therapy across major guidelines
How Other Agents Compare
• Calcium Channel Blockers (CCBs) (e.g., amlodipine)
• Highly effective for systolic BP
• Especially beneficial in older adults
• ACE inhibitors / ARBs
• Moderate SBP reduction
• Preferred when comorbidities are present (diabetes, CKD, heart failure)
Guideline Perspective
• Consensus trends (AHA/ACC 2025, ESC 2024, BIHS 2025):
• Intensive control: near-universal target <130/80 mmHg
• Risk-based treatment: focus on 10- and 30-year risk (e.g., PREVENT)
• Mandatory testing: routine urine ACR for early kidney damage
Clinical Takeaway
Thiazide-like diuretics are the most effective and most commonly used drugs for lowering systolic BP, followed closely by long-acting calcium channel blockers.
Sources-Guideline Background
• ESH Clinical Practice Guidelines 2024
• ESC Guidelines 2024
• ISH – complements ESH/ ESC2024 /ACC-AHA 2025 with global applicability
Key Links
• ESH 2023/2024-concise update :
• AHA/ACC 2025